US 10220078
Methods of using thrombin derivatives to treat medulloblastoma
granted A61KA61K38/4833A61K41/0038
Quick answer
US patent 10220078 (Methods of using thrombin derivatives to treat medulloblastoma) held by The Board of Regents of the University of Texas System expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K38/4833, A61K41/0038